Agreement signedPublished 11 Aug 2023

Swiftmerge Acquisition Corp. /
HDL

Swiftmerge agrees to combine with HDL Therapeutics, Inc.

Buy side: Swiftmerge Acquisition Corp.
Buy sideSwiftmerge Acquisition Corp.
Target: HDL
TargetHDL
Source · 11 Aug 2023
Buy side: Swiftmerge Acquisition Corp.
Buy sideSwiftmerge Acquisition Corp.
Target: HDL
TargetHDL
01 / BuyerSwiftmerge Acquisition Corp.
02 / TargetHDL
01

What happened

Swiftmerge Acquisition Corp. entered into a merger agreement with HDL, with HDL to become a wholly owned subsidiary of Swiftmerge. The transaction provides for cash and shares with a total value of $400,000,000.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Swiftmerge agrees to combine with HDL Therapeutics, Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.